- Land USA
Aktuelle News
News Funktionen
Weitere Funktionen
1 April 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
6 März 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
28 Februar 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
20 Februar 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
2 Januar 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
20 November 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
9 November 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
8 November 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023
8 August 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023
2 August 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023
30 Juni 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI® from Lilly
31 Mai 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
9 Mai 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2023
3 Mai 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023
24 April 2023
Amphastar Pharmaceuticals, Inc.
Lilly to Divest BAQSIMI to Amphastar
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023
12 April 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
8 März 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg
22 Februar 2023
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2023
22 November 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference
10 November 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the 2022 Jefferies London Healthcare Conference
7 November 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2022
28 Oktober 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7, 2022
2 September 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
16 August 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Receives FDA Approval for Epinephrine Pre-Filled Syringes
8 August 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2022
1 August 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2022
19 Juli 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Receives FDA Approval for Vasopressin
6 Juni 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
24 Mai 2022
Amphastar Pharmaceuticals, Inc.
Amphastar Receives FDA Approval for Regadenoson